FDA Updates for the Week of December 19, 2022
In a busy week for FDA approvals, the agency has authorized several first-class therapies: a treatment for HIV-1 and for follicular lymphoma. Other approvals include: Tymlos for osteoporosis in men; Vraylar for major depressive disorder; Cytalux to identify lung cancer during surgery. In COVID-19 news, the agency has approved Actemra for hospitalized patients. The FDA … Read more